We are live on ! Find out more
SWTX

SpringWorks Therapeutics
SWTX

Delisted

SWTX was delisted on the 30th of June, 2025.

Back to rankings

147 hedge funds and large institutions have $1.58B invested in SpringWorks Therapeutics in 2023 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 54 increasing their positions, 48 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

55% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 11

13% more repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 48

4% more funds holding

Funds holding: 142 → 147 (+5)

1.96% less ownership

Funds ownership: 111.38% → 109.42% (-2%)

13% less capital invested

Capital invested by funds: $1.82B → $1.58B (-$242M)

20% less funds holding in top 10

Funds holding in top 10: 5 → 4 (-1)

43% less call options, than puts

Call options by funds: $256K | Put options by funds: $453K

Holders
147
Holders Change
+5
Holders Change %
+3.52%
% of All Funds
2.33%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.06%
New
17
Increased
54
Reduced
48
Closed
11
Calls
$256K
Puts
$453K
Net Calls
-$197K
Net Calls Change
+$47K

Top Buyers

Rank Fund Capital Flow
1
MC
Maverick Capital
Texas
+$17.4M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$5.88M
3
Morgan Stanley
Morgan Stanley
New York
+$5.12M
4
IC
Ikarian Capital
Texas
+$4.88M
5
BlackRock
BlackRock
New York
+$4.55M

Top Sellers

Rank Fund Capital Flow
1
Bank of America
Bank of America
North Carolina
-$29.6M
2
State Street
State Street
Massachusetts
-$16M
3
ITP
Iron Triangle Partners
Connecticut
-$8.61M
4
Goldman Sachs
Goldman Sachs
New York
-$8.59M
5
O
OrbiMed
New York
-$5.74M
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$214M +$190K +6,956 +0.1%
Vanguard Group
2
Vanguard Group
Pennsylvania
$114M +$565K +20,651 +0.4%
BlackRock
3
BlackRock
New York
$102M +$4.55M +166,341 +4%
O
4
OrbiMed
New York
$91.8M -$5.74M -210,000 -5%
DTC
5
Deep Track Capital
Connecticut
$82M – – –
EC
6
EcoR1 Capital
California
$80M – – –
BC
7
Boxer Capital
California
$79.1M – – –
BCLSI
8
Bain Capital Life Sciences Investors
Massachusetts
$71.2M – – –
BBA
9
Baker Bros. Advisors
New York
$69.4M – – –
State Street
10
State Street
Massachusetts
$59.4M -$16M -584,355 -19%
ACH
11
ArrowMark Colorado Holdings
Colorado
$55.4M -$2.78M -101,511 -4%
AG
12
Artal Group
Luxembourg
$42M – – –
DM
13
Deerfield Management
New York
$36.5M +$6.15K +225 +0%
T. Rowe Price Associates
14
T. Rowe Price Associates
Maryland
$36M +$5.88M +214,884 +16%
PA
15
Perceptive Advisors
New York
$35.2M -$465K -17,015 -1%
Marshall Wace
16
Marshall Wace
United Kingdom
$29.8M +$2.2M +80,613 +7%
Geode Capital Management
17
Geode Capital Management
Massachusetts
$27.3M +$3.53M +128,944 +12%
Pictet Asset Management
18
Pictet Asset Management
Switzerland
$24.4M +$28.8M +1,053,857 New
Dimensional Fund Advisors
19
Dimensional Fund Advisors
Texas
$23.4M +$766K +28,016 +3%
Fiera Capital (Canada)
20
Fiera Capital (Canada)
Quebec, Canada
$20.6M +$698K +25,510 +3%
Bank of America
21
Bank of America
North Carolina
$17.3M -$29.6M -1,083,821 -59%
MC
22
Maverick Capital
Texas
$14.7M +$17.4M +637,760 New
Goldman Sachs
23
Goldman Sachs
New York
$13.7M -$8.59M -314,092 -35%
JP Morgan Chase
24
JP Morgan Chase
New York
$13.1M -$850K -31,082 -5%
FC
25
Finepoint Capital
Massachusetts
$12.9M -$1.41M -51,700 -8%
1
2 3 4 5

SWTX Hedge Fund Activity: Q3 2023 in Review

147 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in SpringWorks Therapeutics (SWTX) for Q3 2023, worth a combined $1.58B — down 13% from $1.82B a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new SWTX positions and 11 closed out — a net gain of 6 holders — while 54 added to existing stakes and 48 trimmed.

The largest buyer was Maverick Capital, opening a new position worth an estimated $17.4M. The largest seller was Bank of America, cutting an estimated $29.6M.

  • 147 institutional investors held SpringWorks Therapeutics (SWTX) as of Q3 2023, up from 142 in Q2 2023.
  • Funds reported $1.58B of SpringWorks Therapeutics stock for Q3 2023, down 13% quarter-over-quarter.
  • 17 funds opened new SpringWorks Therapeutics positions in Q3 2023 and 11 closed out, a net change of +6 holders.
  • The largest SpringWorks Therapeutics buyer in Q3 2023 was Maverick Capital, an estimated $17.4M added.
  • The largest SpringWorks Therapeutics seller in Q3 2023 was Bank of America, an estimated $29.6M sold.

Based on aggregated 13F filings for Q3 2023.